DrugDashboards

Ketorolac Tromethamine

Ketorolac Tromethamine · KETOROLAC TROMETHAMINE 30 mg/mL · Injection · Intramuscular; Intravenous · Hikma Pharmaceuticals USA Inc.

NDC 00641-6042-25 · 25 VIAL in 1 CARTON / 1 mL in 1 VIAL · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 15% over the past year, to $1.04 per mL. It is in shortage right now — FDA lists the reason as “other”. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.04per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$3.16per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00$6.00May 2016Sep 2026$1.04
60 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$39.55
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$11,362
3,355 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

35● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • in shortage now+25
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for ketorolac tromethamine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $22.07 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA075772
TE code
AP
Approval date
Jul 21, 2004
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Jun 6, 2018
    Other
    month 99 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

  • Class II · TerminatedDec 17, 2019
    Hikma Pharmaceuticals USA Inc. — Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
  • Class I · TerminatedDec 17, 2019
    Hikma Pharmaceuticals USA Inc. — Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Manufacturers of Ketorolac Tromethamine (Injection)

LabelerStrengthFirst seenLast seen
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 3, 2026
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 3, 2026
Onesource Specialty Pharma LimitedKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026
Nephron Pharmaceuticals CorporationKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCKETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
SOLA Pharmaceuticals, LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCKETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 15 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 30 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.KETOROLAC TROMETHAMINE 60 mg/2mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketorolac Tromethamine — NDC 00641-6042-25," retrieved September 3, 2026, https://drugdashboards.com/drug/00641604225.

Free to cite with attribution — see how the data is put together.